라우르산의 양을 변화시킴으로써 잠재적인 암 요법을 갖는 전분-라우르산(starch-lauric acid; St-LA) 나노 입자를 제조하고 최적화된 St-LA 나노 입자를 발견하였다. 또한 주사 전자 현미경(SEM) 및 ...
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A107258407
2021
English
KCI등재,SCIE,SCOPUS
학술저널
62-67(6쪽)
0
0
상세조회0
다운로드국문 초록 (Abstract)
라우르산의 양을 변화시킴으로써 잠재적인 암 요법을 갖는 전분-라우르산(starch-lauric acid; St-LA) 나노 입자를 제조하고 최적화된 St-LA 나노 입자를 발견하였다. 또한 주사 전자 현미경(SEM) 및 ...
라우르산의 양을 변화시킴으로써 잠재적인 암 요법을 갖는 전분-라우르산(starch-lauric acid; St-LA) 나노 입자를 제조하고 최적화된 St-LA 나노 입자를 발견하였다. 또한 주사 전자 현미경(SEM) 및 푸리에 변환 적외선 분광법(FTIR) 분석을 통해 St-LA 나노 입자가 성공적으로 제조되었음을 확인하였다. 세포 실험에서, St-LA 나노 입자는 A549 및 Caco-2 세포에서 세포 독성을 나타내지만 NIH/3T3 세포는 나타내지 않았음이 LIVE/DEAD 염색 및 형광 이미징에 의해 확인되었다. 따라서 St-LA 나노 입자는 잠재적으로 암 화학 요법에 적용될 수 있을 것으로 판단된다.
다국어 초록 (Multilingual Abstract)
This manuscript reports on the fabrication of starch-lauric acid (St-LA) nanoparticles having potential cancer therapy. St-LA nanoparticles were fabricated by varying the amount of LA, and the optimized St-LA nanoparticles were found. In addition, it ...
This manuscript reports on the fabrication of starch-lauric acid (St-LA) nanoparticles having potential cancer therapy. St-LA nanoparticles were fabricated by varying the amount of LA, and the optimized St-LA nanoparticles were found. In addition, it was confirmed that the St-LA nanoparticles were successfully fabricated through scanning electron microscopy (SEM) and Fourier transform infrared spectroscopy (FTIR) analysis. In vitro, the St-LA nanoparticles showed cytotoxicity in A549 and Caco-2 cells but not NIH/3T3 cells. These results were confirmed by LIVE/DEAD staining and fluorescence imaging. Our next goal is to evaluate the St-LA nanoparticles containing various anticancer drugs through in vitro and in vivo studies. St-LA nanoparticles can potentially be applied to cancer chemotherapy.
목차 (Table of Contents)
참고문헌 (Reference)
1 박준규, "소수성 항암제의 전달체로 응용하기 위한 리소콜릭산이 결합된 키토산 나노입자의 제조와 특성" 한국고분자학회 32 (32): 263-269, 2008
2 Torchilin, V., "Tumor Delivery of Macromolecular Drugs Based on the EPR Effect" 63 : 131-135, 2011
3 Dayrit, F. M., "The Properties of Lauric Acid and Their Significance in Coconut Oil" 92 : 1-15, 2015
4 Lappano, R., "The Lauric Acid-activated Signaling Prompts Apoptosis in Cancer Cells" 3 : 17063-, 2017
5 Yang, D., "The Antimicrobial Activity of Liposomal Lauric Acids Against Propionibacterium Acnes" 30 : 6035-6040, 2009
6 Wang, M., "Targeting Nanoparticles to Cancer" 62 : 90-99, 2010
7 Scott, R. W. J., "Synthesis, Characterization, and Applications of Dendrimer-Encapsulated Nanoparticles" 109 : 692-704, 2005
8 Khanal, A., "Synthesis of Silica Hollow Nanoparticles Templated by Polymeric Micelle with Core−Shell−Corona Structure" 129 : 1534-1535, 2007
9 Lu, D. R., "Starch-based Completely Biodegradable Polymer Materials" 3 : 366-375, 2009
10 Na, K., "Self-assembled Hydrogel Nanoparticles from Curdlan Derivatives: Characterization, Anti-cancer Drug Release and Interaction with a Hepatoma Cell Line (HepG2)" 69 : 225-236, 2000
1 박준규, "소수성 항암제의 전달체로 응용하기 위한 리소콜릭산이 결합된 키토산 나노입자의 제조와 특성" 한국고분자학회 32 (32): 263-269, 2008
2 Torchilin, V., "Tumor Delivery of Macromolecular Drugs Based on the EPR Effect" 63 : 131-135, 2011
3 Dayrit, F. M., "The Properties of Lauric Acid and Their Significance in Coconut Oil" 92 : 1-15, 2015
4 Lappano, R., "The Lauric Acid-activated Signaling Prompts Apoptosis in Cancer Cells" 3 : 17063-, 2017
5 Yang, D., "The Antimicrobial Activity of Liposomal Lauric Acids Against Propionibacterium Acnes" 30 : 6035-6040, 2009
6 Wang, M., "Targeting Nanoparticles to Cancer" 62 : 90-99, 2010
7 Scott, R. W. J., "Synthesis, Characterization, and Applications of Dendrimer-Encapsulated Nanoparticles" 109 : 692-704, 2005
8 Khanal, A., "Synthesis of Silica Hollow Nanoparticles Templated by Polymeric Micelle with Core−Shell−Corona Structure" 129 : 1534-1535, 2007
9 Lu, D. R., "Starch-based Completely Biodegradable Polymer Materials" 3 : 366-375, 2009
10 Na, K., "Self-assembled Hydrogel Nanoparticles from Curdlan Derivatives: Characterization, Anti-cancer Drug Release and Interaction with a Hepatoma Cell Line (HepG2)" 69 : 225-236, 2000
11 Yan, W., "Recent Advances in Liposome-Based Nanoparticles for Antigen Delivery" 47 : 329-344, 2007
12 Do Van Cong, "Preparation and Characterization of Nanocomposites Based on Poly(ethylene-co-vinyl acetate), Polylactic Acid, and TiO2 Nanoparticles" 한국고분자학회 40 (40): 355-364, 2016
13 Lee, J. -H., "Polymeric Nanoparticle Composed of Fatty Acids and Poly(ethylene glycol) as a Drug Carrier" 251 : 23-32, 2003
14 김유미, "Paclitaxel-loaded Nanoparticles of Cholanic Acid-Modified Hyaluronan Oligosaccharide for Tumor-site Specific Delivery" 한국고분자학회 39 (39): 967-975, 2015
15 Matés, J. M., "Oxidative Stress in Apoptosis and Cancer: An Update" 86 : 1649-1665, 2012
16 Ozben, T., "Oxidative Stress and Apoptosis: Impact on Cancer Therapy" 96 : 2181-2196, 2007
17 Tracey, T. J., "Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease" 11 : 1-25, 2018
18 Haley, B., "Nanoparticles for Drug Delivery in Cancer Treatment" 26 : 57-64, 2008
19 Singh, R., "Nanoparticle-based Targeted Drug Delivery" 86 : 215-223, 2009
20 Hu, C. -M. J., "Nanoparticle-assisted Combination Therapies for Effective Cancer Treatment" 1 : 323-334, 2010
21 Kong, J. Y., "Lovastatin Does Not Accentuate but is Rather Additive to Palmitate-induced Apoptosis in Cardiomyocytes" 67 : 293-302, 2002
22 Calder, P. C., "Long-chain Fatty Acids and Inflammation" 71 : 284-289, 2012
23 Veeresh Babu, S. V., "Lauric acid and Myristic Acid Prevent Testosterone Induced Prostatic Hyperplasia in Rats" 626 : 262-265, 2010
24 Weng, W. -H., "Lauric Acid Can Improve The Sensitization of Cetuximab in KRAS/BRAF Mutated Colorectal Cancer Cells by Retrievable microRNA-378Expression" 35 : 107-116, 2016
25 Xu, Z. P., "Inorganic Nanoparticles as Carriers for Efficient Cellular Delivery" 61 : 1027-1040, 2006
26 Odenigbo, U. M., "Fatty Acids and Phytochemical Contents of Different Coconut Seed Flesh in Nigeria" 3 : 176-182, 2011
27 Kunishima, M., "Esterification of Carboxylic Acids with Alcohols by 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methyl-morpholinium Chloride (DMTMM)" 8 : 1255-1256, 1999
28 Zhang, H. Y., "Ergosterol-loaded Poly(lactide-co-glycolide) Nanoparticles with Enhanced In Vitro Antitumor Activity and Oral Bioavailability" 37 : 834-844, 2016
29 Kulkarni, S. A., "Effects of Particle Size and Surface Modification on Cellular Uptake and Biodistribution of Polymeric Nanoparticles for Drug Delivery" 30 : 2512-2522, 2013
30 Win, K. Y., "Effects of Particle Size and Surface Coating on Cellular Uptake of Polymeric Nanoparticles for Oral Delivery of Anticancer Drugs" 26 : 2713-2722, 2005
31 He, C., "Effects of Particle Size and Surface Charge on Cellular Uptake and Biodistribution of Polymeric Nanoparticles" 31 : 3657-3666, 2010
32 Lehto, V.-P., "EGF Receptor: Which Way to Go?" 491 : 1-3, 2001
33 Lim, S. A., "Chlorin E6-embedded Starch Nanogels for Improved Photodynamic Tumor Ablation" 29 : 2766-2773, 2018
34 Song, S., "Carbon Nanotube/reduced Graphene Oxide Hybrid for Simultaneously Enhancing the Thermal Conductivity and Mechanical Properties of Styrene -butadiene Rubber" 123 : 158-167, 2017
35 Bhunia, S. K., "Carbon Nanoparticle-based Fluorescent Bioimaging Probes" 3 : 1473-, 2013
36 Kumari, A., "Biodegradable Polymeric Nanoparticles Based Drug Delivery Systems" 75 : 1-18, 2010
37 Agoramoorthy, G., "Antibacterial and Antifungal Activities of Fatty Acid Methyl Esters of the Blind-your-eye Mangrove from India" 38 : 739-742, 2007
38 D’Este, M., "A Systematic Analysis of DMTMM vs EDC/NHS for Ligation of Amines to Hyaluronan in Water" 108 : 239-246, 2014
Synthesis and Application of Cationic Waterborne Polyurethane as Fixing Agent for Cotton Fabric
PA66/GF소재의 가공, 계면결합 및 물성증가에 아연이온이 미치는 영향
Facile and Fast Photo-Polymerization of N-Vinyl Caprolactam via UV-C Irradiation
학술지 이력
연월일 | 이력구분 | 이력상세 | 등재구분 |
---|---|---|---|
2023 | 평가예정 | 해외DB학술지평가 신청대상 (해외등재 학술지 평가) | |
2020-01-01 | 평가 | 등재학술지 유지 (해외등재 학술지 평가) | |
2012-06-04 | 학술지명변경 | 외국어명 : 미등록 -> POLYMER(KOREA) | |
2010-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2008-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2006-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2004-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2001-07-01 | 평가 | 등재학술지 선정 (등재후보2차) | |
1999-01-01 | 평가 | 등재후보학술지 선정 (신규평가) |
학술지 인용정보
기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
---|---|---|---|
2016 | 0.58 | 0.47 | 0.5 |
KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
0.45 | 0.43 | 0.401 | 0.13 |